Search results

1. ASCO 2025 – BioNTech has a prostate decision to make

   ASCO 2025 – BioNTech has a prostate decision to make …

   
    

   Madeleine Armstrong
    
   - 06/02/2025 - 01:27

2. ASCO 2025 – J&J takes another prostate cancer shot

   ASCO 2025 – J&J takes another prostate cancer shot … 4-8 only; ^^RP2D only; ^^^across whole trial. Source: ASCO 2025, OncologyPipeline & company presentations.   …

   
    

   Madeleine Armstrong
    
   - 06/02/2025 - 00:44

3. ASCO 2025 – Bicara's ficerafusp claim turns to PD-L1 status

   ASCO 2025 – Bicara's ficerafusp claim turns to PD-L1 …

   
    

   Jacob Plieth
    
   - 06/01/2025 - 21:14

4. ASCO 2025 – Astra "looked at" patritumab but passed

   ASCO 2025 – Astra "looked at" patritumab but passed …

   
    

   Jacob Plieth
    
   - 06/01/2025 - 21:23

5. ASCO 2025 – Dizal goes after the BTK leaders

   ASCO 2025 – Dizal goes after the BTK leaders …

   
    

   Jacob Plieth
    
   - 06/01/2025 - 21:24

6. ASCO 2025 – BioNTech’s latest Claudin6 effort falls short

   ASCO 2025 – BioNTech’s latest Claudin6 effort falls … Note: *another 4 responses were unconfirmed. Source: ASCO 2025 & ESMO 2024.   Complicating the cross-trial …

   
    

   Madeleine Armstrong
    
   - 06/01/2025 - 21:08

7. ASCO 2025 – 3SBio reveals what Pfizer got for its $1.25bn

   ASCO 2025 – 3SBio reveals what Pfizer got for its $1.25bn …

   
    

   Jacob Plieth
    
   - 06/01/2025 - 21:06

8. ASCO 2025 – Exelixis’s son of Cabometyx improves

   ASCO 2025 – Exelixis’s son of Cabometyx improves …

   
    

   Madeleine Armstrong
    
   - 06/01/2025 - 21:07

9. ASCO 2025 – zilo-V adds a patient death to its tox tally

   ASCO 2025 – zilo-V adds a patient death to its tox tally …

   
    

   Jacob Plieth
    
   - 06/01/2025 - 21:07

10. ASCO 2025 – Astra's Matterhorn could break new ground

    ASCO 2025 – Astra's Matterhorn could break new ground …

    
     

    Jacob Plieth
     
    - 06/01/2025 - 21:22